510(k) · Cleared
ClearedAspartate Amino Transferase (Ast/Sgot) Test System, Asat (Got) FS
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Diasys Diagnostics Systems GmbH · CIT Nadh Oxidation/Nad Reduction, Ast/Sgot
Cleared on Dec 4, 2008 as substantially equivalent to K924244 (Roche Diagnostic Systems, Inc., 1993) and 2 other predicates after a 286-day review. Its family tree reaches back 3 generations to 1981.
- Decided
- Dec 4, 2008
- Review
- 286 days
- Class
- Class II
- Product code
- CIT
- Recalls
- None
- Predicates
- 3
Its longest line of descent runs back 3 generations to K811832 (1981). 5 ancestors in all. No later device cites it as a predicate yet.
- Root · 3 generations backK811832 Precinorm U & Precipath U Human SerumBoehringer Mannheim Corp. · 1981
- 2 generations backK993360 Precinorm Universal Plus and Precipath Universal Plus Control SeraRoche Diagnostics Corp. · 1999
- 1 generation backK042389 Modification to Precinorm Universal Plus and Precipath Universal…Roche Diagnostics Corp. · 2004
- This deviceK080485 Aspartate Amino Transferase (Ast/Sgot) Test System, Asat (Got) FSDiasys Diagnostics Systems GmbH · 2008
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −3 | K811832 | Precinorm U & Precipath U Human Serum | Boehringer Mannheim Corp. | 1981 | — |
| −2 | K993360 | Precinorm Universal Plus and Precipath Universal Plus Control Sera | Roche Diagnostics Corp. | 1999 | — |
| −1 | K042389 | Modification to Precinorm Universal Plus and Precipath Universal Plus Control… | Roche Diagnostics Corp. | 2004 | — |
| 0 (this device) | K080485 | Aspartate Amino Transferase (Ast/Sgot) Test System, Asat (Got) FS | Diasys Diagnostics Systems GmbH | 2008 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1993 | 1 | 0 |
| 1999 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in CIT? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (3)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K924244 | Roche Reagent for AstSummary page 2…Page 1 D. Predicate Device Roche/Hitachi AST (ASAT/GOT) Aspartate aminotransferase ace. to IFCC with/without pynidoxal phosphate activation (k924244) Roche Calibrator for automated systems (C.f.a.s.) (k990460). Roche Precinorm Universal Plus and Precipath Universal Plus contr… | 1993 |
| * | K990460 | Calibrator for Automated Systems (C.F.a.S.)Summary page 2…/Hitachi AST (ASAT/GOT) Aspartate aminotransferase ace. to IFCC with/without pynidoxal phosphate activation (k924244) Roche Calibrator for automated systems (C.f.a.s.) (k990460). Roche Precinorm Universal Plus and Precipath Universal Plus controls (k042389). E. Device Description and Explanation of the… | 1999 |
| * | K042389 | Modification to Precinorm Universal Plus and Precipath Universal Plus Control SeraSummary page 2…doxal phosphate activation (k924244) Roche Calibrator for automated systems (C.f.a.s.) (k990460). Roche Precinorm Universal Plus and Precipath Universal Plus controls (k042389). E. Device Description and Explanation of the Test The DiaSys ASAT (GOT) FS assay is based on NADH reduction to NAD, as shown… | 2004 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 27 years and passes through 3 companies; a new generation was cleared every 4.8 years on median.
- None of the 5 ancestors has a recall.
- 1 other device also cites its predicate K924244.
How does its category compare?
All CIT devicesCIT Nadh Oxidation/Nad Reduction, Ast/Sgot: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.
FDA decisions per year · CIT
1in 2010
2026 to Oct 25, outlined.
Median 510(k) review, days · CIT
Too few CIT 510(k)s in any year since 2007 to give a median.
Recalls per year · CIT
1in 2023
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · CIT
10in 2025
MAUDE reports naming product code CIT, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 2 | — | 0 | 23 |
| 2008 | 2 | — | 3 | 17 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 1 | — | 0 | 1 |
| 2011 | 0 | — | 0 | 7 |
| 2012 | 0 | — | 1 | 2 |
| 2013 | 0 | — | 1 | 0 |
| 2014 | 0 | — | 1 | 0 |
| 2015 | 0 | — | 0 | 1 |
| 2016 | 0 | — | 0 | 0 |
| 2017 | 0 | — | 0 | 2 |
| 2018 | 0 | — | 0 | 1 |
| 2019 | 0 | — | 0 | 2 |
| 2020 | 0 | — | 0 | 1 |
| 2021 | 0 | — | 0 | 5 |
| 2022 | 0 | — | 0 | 2 |
| 2023 | 0 | — | 1 | 2 |
| 2024 | 0 | — | 0 | 8 |
| 2025 | 0 | — | 0 | 10 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
ASAT (GOT) FS The ASAT (GOT) FS assay is intended for quantitative in vitro diagnostic determination of the activity of the enzyme aspartate amino transferase (AST) in human serum and lithium heparin plasma on the Hitachi 917 instrument. Measurement of aspartate amino transferase levels aids in the diagnosis and treatment of certain types of liver and heart disease. TruCal U For In vitro diagnostic use on the Hitachi 917 instrument. TruCal U is used as a…
Read the full statement (124 words)
ASAT (GOT) FS
The ASAT (GOT) FS assay is intended for quantitative in vitro diagnostic determination of the activity of the enzyme aspartate amino transferase (AST) in human serum and lithium heparin plasma on the Hitachi 917 instrument. Measurement of aspartate amino transferase levels aids in the diagnosis and treatment of certain types of liver and heart disease.
TruCal U
For In vitro diagnostic use on the Hitachi 917 instrument. TruCal U is used as a calibrator for the DiaSys ASAT (GOT) FS assay.
TruLab N and TruLab P Controls
For in vitro diagnostic use for quantitative testing on the Hitachi 917 instrument. TruLab N and TruLab P control sera are used to monitor accuracy and precision for the DiaSys ASAT (GOT) FS assay.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K080485 · printed Nov 3, 2026
Cite this page
510(k) Report. “K080485: Aspartate Amino Transferase (Ast/Sgot) Test System, Asat (Got) FS.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 3, 2026. https://510kreport.com/device/K080485
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026